Interim analysis from the OPTIC trial - A dose-ranging study of 3 starting doses of ponatinib Meeting Abstract
| Authors: | Cortes, J.; Lomaia, E.; Turkina, A.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Rojas, C.; Chuah, C.; Arthur, C.; Apperley, J.; Kim, D. W.; Hochhaus, A.; Rousselot, P.; Rosti, G.; Mauro, M.; Lipton, J.; Naranjo, D.; Liu, G. H.; Srivastava, S.; Deininger, M. |
| Abstract Title: | Interim analysis from the OPTIC trial - A dose-ranging study of 3 starting doses of ponatinib |
| Meeting Title: | 8th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | cml; chronic myeloid leukemia; acute lymphoblastic leukemia; tyrosine kinase inhibitor; ponatinib; dose-ranging; optic; t315i |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 20 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Sep 9-12 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-09-01 |
| Start Page: | S234 |
| Language: | English |
| ACCESSION: | WOS:000564055100188 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(20)30815-6 |
| Notes: | Meeting Abstract: CML-114 -- Due to COVID-19 pandemic, the conference was held virtually-- Source: Wos |
